학술논문

Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study
Document Type
Article
Source
In The Lancet Infectious Diseases September 2022 22(9):1303-1312
Subject
Primary Research
Articles
Language
ISSN
1473-3099